섭취 가능 스마트 필 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Ingestible Smart Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,970,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,179,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,853,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

이 보고서는 전 세계 섭취 가능 스마트 필 시장을 조사하여 성분별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 주요 요약

제2장 섭취 가능 스마트 필 시장 소개

제3장 섭취 가능 스마트 필 시장 분석 시나리오

• 가격 분석
• 시장과 예측

제4장 섭취 가능 스마트 필 시장 역학

• 거시경제 요인
• 성장 촉진요인
• 성장 억제요인
• 기회
• 동향
• Porter's Five Forces 분석
• 밸류체인 분석

제5장 세계의 섭취 가능 스마트 필 시장 분석과 예측 : 성분별

• 소개
• 섭취 가능 스마트 필 시장 예측 : 성분별
• 시장 매력 분석 : 성분별

제6장 세계의 섭취 가능 스마트 필 시장 분석과 예측 : 용도별

• 소개
• 섭취 가능 스마트 필 시장 예측 : 용도별
• 시장 매력 분석 : 용도별

제7장 세계의 섭취 가능 스마트 필 시장 분석과 예측 : 최종사용자별

• 소개
• 섭취 가능 스마트 필 시장 예측 : 최종사용자별
• 섭취 가능 스마트 필 시장 매력 분석 : 최종사용자별

제8장 세계의 섭취 가능 스마트 필 시장 분석과 예측 : 지역별

• 소개
• 섭취 가능 스마트 필 시장 예측 : 지역별
• 섭취 가능 스마트 필 시장 매력 분석 : 지역별

제9장 북미의 섭취 가능 스마트 필 시장 분석과 예측

제10장 라틴아메리카의 섭취 가능 스마트 필 시장 분석과 예측

제11장 유럽의 섭취 가능 스마트 필 시장 분석과 예측

제12장 아시아태평양의 섭취 가능 스마트 필 시장 분석과 예측

제13장 중동 및 아프리카의 섭취 가능 스마트 필 시장 분석과 예측

제14장 경쟁 상황

• 경쟁 대시보드
• 기업 개요(상세 - 개요, 재무, 전략, 최근의 동향)
• 세계의 시장 진출 기업
  • BodyCap-Medical
  • Philips Respironics
  • Given Imaging Ltd.
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • CapsoVision, Inc.
  • Chongqing Jinshan Science and Component(Group) Co., Ltd.
  • Medimetrics
  • IntroMedic Co., Ltd.
  • Check-Cap Ltd.
• 사용되는 전제와 두문자어
• 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Ingestible Smart Pills market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

• Ingestible Smart Pills Market Size (2024E): USD 1,200.00 Mn
• Projected Market Value (2031F): USD 1,852.60 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 6.4%

Ingestible Smart Pills Market - Report Scope:

Ingestible smart pills represent a significant innovation in healthcare, offering a new approach to diagnosis, patient monitoring, and drug delivery. These tiny devices, ingested orally, are capable of gathering essential data from within the body, transmitting it externally for medical analysis. The primary application areas include gastrointestinal diagnostics, patient monitoring for chronic conditions, and real-time drug effectiveness evaluation. Market growth is primarily driven by the rising demand for minimally invasive diagnostic tools, advancements in sensor technology, and an aging population with increasing healthcare needs.

Market Growth Drivers:

The global Ingestible Smart Pills market is driven by several key factors, including the increasing prevalence of chronic gastrointestinal diseases, which fuels demand for non-invasive diagnostic and monitoring solutions. Advances in sensor technology and miniaturization enable the development of compact, efficient ingestible pills. Rising healthcare awareness and the emphasis on preventive care, along with the growth of digital health technologies, contribute to the market's expansion. The healthcare industry's shift towards personalized medicine also supports the adoption of smart pills, as these devices offer precise, patient-specific data that can guide treatment decisions.

Market Restraints:

Despite promising growth, the Ingestible Smart Pills market faces challenges such as high development and manufacturing costs, stringent regulatory requirements, and limited consumer awareness in emerging regions. The need for specialized facilities and technical expertise to manufacture these devices adds to the overall cost, potentially limiting accessibility. Furthermore, regulatory agencies demand rigorous testing for safety and efficacy, which can delay product launches and increase compliance costs. Privacy concerns surrounding patient data collected by ingestible pills may also hinder adoption, especially in regions with stringent data protection laws.

Market Opportunities:

The Ingestible Smart Pills market presents substantial opportunities with expanding applications across healthcare sectors. There is significant growth potential in new areas like personalized drug delivery and in-patient monitoring for cardiovascular and respiratory conditions. Collaborations between technology firms and healthcare providers could lead to novel solutions that further enhance patient outcomes. Additionally, advances in AI and machine learning could facilitate the development of more sophisticated analysis systems for data collected by ingestible pills, providing deeper insights and enabling predictive diagnostics. Emerging markets with growing healthcare infrastructure also present opportunities for expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Ingestible Smart Pills market globally?
• Which application areas are leading in the adoption of ingestible smart pill technology?
• How are advancements in sensor technology shaping the competitive landscape of the Ingestible Smart Pills market?
• Who are the key players in the Ingestible Smart Pills market, and what strategies are they using to maintain competitiveness?
• What are the emerging trends and future prospects in the global Ingestible Smart Pills market?

Competitive Intelligence and Business Strategy:

Key players in the global Ingestible Smart Pills market, including Proteus Digital Health, CapsoVision, and Medtronic, are focused on innovation, research, and strategic partnerships to maintain a competitive edge. Companies are investing in R&D to enhance the functionality and accessibility of smart pills, targeting improvements in battery life, data transmission capabilities, and patient comfort. Collaborations with healthcare providers, research institutions, and pharmaceutical companies enable them to extend their market reach and develop targeted solutions. Prioritizing compliance with regulatory standards and data security practices is crucial for fostering consumer trust and encouraging widespread adoption of smart pill technology.

Key Companies Profiled:

• BodyCap-Medical
• Philips Respironics
• Given Imaging Ltd.
• Olympus Corporation
• Proteus Digital Health, Inc.
• CapsoVision, Inc.
• Chongqing Jinshan Science and Component (Group) Co., Ltd.
• Medimetrics
• IntroMedic Co., Ltd.
• Check-Cap Ltd.
• Others

Ingestible Smart Pills Industry Segmentation:

By Component

• Smart Pills
• Workstation

By Application

• Imaging
• Monitoring

By End User

• Hospitals
• Clinics
• Research Institutes
• Home Healthcare

By Region

• North America
• Europe
• Latin America
• APAC
• MEA

Table of Contents

1. Executive Summary

2. Ingestible Smart Pills Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy
• 2.3. Key Industry Developments

3. Ingestible Smart Pills Market Analysis Scenario

• 3.1. Pricing Analysis
  • 3.1.1. Pricing Assumptions
  • 3.1.2. Price Projections Per Region
• 3.2. Market Size (US$ Mn) and Forecast
  • 3.2.1. Market Size and Y-o-Y Growth
  • 3.2.2. Absolute $ Opportunity

4. Ingestible Smart Pills Market Dynamics

• 4.1. Macro-economic Factors
• 4.2. Drivers
• 4.3. Restraints
• 4.4. Opportunities
• 4.5. Trends
• 4.6. Porters Five Forces Analysis
• 4.7. Value Chain Analysis

5. Global Ingestible Smart Pills Market Analysis and Forecast, By Component

• 5.1. Introduction
  • 5.1.1. Basis Point Share (BPS) Analysis By Component
  • 5.1.2. Y-o-Y Growth Projections By Component
• 5.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 5.2.1. Smart Pills
    • 5.2.1.1. Patient Monitoring
    • 5.2.1.2. Capsule Endoscopy
      • 5.2.1.2.1. Small Bowel Endoscopy
      • 5.2.1.2.2. Esophagus Endoscopy
      • 5.2.1.2.3. Colon Endoscopy
  • 5.2.2. Workstation
• 5.3. Market Attractiveness Analysis By Component

6. Global Ingestible Smart Pills Market Analysis and Forecast, By Application

• 6.1. Introduction
  • 6.1.1. Basis Point Share (BPS) Analysis By Application
  • 6.1.2. Y-o-Y Growth Projections By Application
• 6.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 6.2.1. Imaging
  • 6.2.2. Monitoring
• 6.3. Market Attractiveness Analysis By Application

7. Global Ingestible Smart Pills Market Analysis and Forecast, By End User

• 7.1. Introduction
  • 7.1.1. Basis Point Share (BPS) Analysis By End User
  • 7.1.2. Y-o-Y Growth Projections By End User
• 7.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 7.2.1. Hospitals
  • 7.2.2. Clinics
  • 7.2.3. Research Institutes
  • 7.2.4. Home Healthcare
• 7.3. Ingestible Smart Pills Market Attractiveness Analysis By End User

8. Global Ingestible Smart Pills Market Analysis and Forecast, By Region

• 8.1. Introduction
  • 8.1.1. Basis Point Share (BPS) Analysis By Region
  • 8.1.2. Y-o-Y Growth Projections By Region
• 8.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Region
  • 8.2.1. North America
  • 8.2.2. Latin America
  • 8.2.3. Europe
  • 8.2.4. Asia Pacific
  • 8.2.5. Middle East and Africa
• 8.3. Ingestible Smart Pills Market Attractiveness Analysis By Region

9. North America Ingestible Smart Pills Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Basis Point Share (BPS) Analysis By Country
  • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.1.3. Key Regulations
• 9.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 9.3.1. Smart Pills
    • 9.3.1.1. Patient Monitoring
    • 9.3.1.2. Capsule Endoscopy
      • 9.3.1.2.1. Small Bowel Endoscopy
      • 9.3.1.2.2. Esophagus Endoscopy
      • 9.3.1.2.3. Colon Endoscopy
  • 9.3.2. Workstation
• 9.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 9.4.1. Imaging
  • 9.4.2. Monitoring
• 9.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 9.5.1. Hospitals
  • 9.5.2. Clinics
  • 9.5.3. Research Institutes
  • 9.5.4. Home Healthcare
• 9.6. Market Attractiveness Analysis
  • 9.6.1. By Country
  • 9.6.2. By Component
  • 9.6.3. By Application
  • 9.6.4. By End User
• 9.7. Prominent Trends
• 9.8. Drivers and Restraints: Impact Analysis

10. Latin America Ingestible Smart Pills Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Basis Point Share (BPS) Analysis By Country
  • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.1.3. Key Regulations
• 10.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
  • 10.2.1. Brazil
  • 10.2.2. Mexico
  • 10.2.3. Rest of Latin America
• 10.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 10.3.1. Smart Pills
    • 10.3.1.1. Patient Monitoring
    • 10.3.1.2. Capsule Endoscopy
      • 10.3.1.2.1. Small Bowel Endoscopy
      • 10.3.1.2.2. Esophagus Endoscopy
      • 10.3.1.2.3. Colon Endoscopy
  • 10.3.2. Workstation
• 10.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 10.4.1. Imaging
  • 10.4.2. Monitoring
• 10.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 10.5.1. Hospitals
  • 10.5.2. Clinics
  • 10.5.3. Research Institutes
  • 10.5.4. Home Healthcare
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Country
  • 10.6.2. By Component
  • 10.6.3. By Application
  • 10.6.4. By End User
• 10.7. Prominent Trends
• 10.8. Drivers and Restraints: Impact Analysis

11. Europe Ingestible Smart Pills Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Basis Point Share (BPS) Analysis By Country / Region
  • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.1.3. Key Regulations
• 11.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country/Region
  • 11.2.1. Germany
  • 11.2.2. France
  • 11.2.3. Italy
  • 11.2.4. Spain
  • 11.2.5. U.K.
  • 11.2.6. Russia
  • 11.2.7. Rest of Western Europe
• 11.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 11.3.1. Smart Pills
    • 11.3.1.1. Patient Monitoring
    • 11.3.1.2. Capsule Endoscopy
      • 11.3.1.2.1. Small Bowel Endoscopy
      • 11.3.1.2.2. Esophagus Endoscopy
      • 11.3.1.2.3. Colon Endoscopy
  • 11.3.2. Workstation
• 11.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 11.4.1. Imaging
  • 11.4.2. Monitoring
• 11.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 11.5.1. Hospitals
  • 11.5.2. Clinics
  • 11.5.3. Research Institutes
  • 11.5.4. Home Healthcare
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Country
  • 11.6.2. By Component
  • 11.6.3. By Application
  • 11.6.4. By End User
• 11.7. Prominent Trends
• 11.8. Drivers and Restraints: Impact Analysis

12. Asia Pacific Ingestible Smart Pills Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Basis Point Share (BPS) Analysis By Country
  • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.1.3. Key Regulations
• 12.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
  • 12.2.1. India
  • 12.2.2. China
  • 12.2.3. Australia and New Zealand
  • 12.2.4. ASEAN
  • 12.2.5. Rest of APEJ
• 12.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 12.3.1. Smart Pills
    • 12.3.1.1. Patient Monitoring
    • 12.3.1.2. Capsule Endoscopy
      • 12.3.1.2.1. Small Bowel Endoscopy
      • 12.3.1.2.2. Esophagus Endoscopy
      • 12.3.1.2.3. Colon Endoscopy
  • 12.3.2. Workstation
• 12.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 12.4.1. Imaging
  • 12.4.2. Monitoring
• 12.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 12.5.1. Hospitals
  • 12.5.2. Clinics
  • 12.5.3. Research Institutes
  • 12.5.4. Home Healthcare
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Country
  • 12.6.2. By Component
  • 12.6.3. By Application
  • 12.6.4. By End User
• 12.7. Prominent Trends
• 12.8. Drivers and Restraints: Impact Analysis

13. Middle East & Africa (MEA) Ingestible Smart Pills Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Basis Point Share (BPS) Analysis By Country
  • 13.1.2. Y-o-Y Growth Projections By Country
  • 13.1.3. Key Regulations
• 13.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
  • 13.2.1. GCC Countries
  • 13.2.2. South Africa
  • 13.2.3. Rest of MEA
• 13.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
  • 13.3.1. Smart Pills
    • 13.3.1.1. Patient Monitoring
    • 13.3.1.2. Capsule Endoscopy
      • 13.3.1.2.1. Small Bowel Endoscopy
      • 13.3.1.2.2. Esophagus Endoscopy
      • 13.3.1.2.3. Colon Endoscopy
  • 13.3.2. Workstation
• 13.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
  • 13.4.1. Imaging
  • 13.4.2. Monitoring
• 13.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
  • 13.5.1. Hospitals
  • 13.5.2. Clinics
  • 13.5.3. Research Institutes
  • 13.5.4. Home Healthcare
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Country
  • 13.6.2. By Component
  • 13.6.3. By Application
  • 13.6.4. By End User
• 13.7. Prominent Trends
• 13.8. Drivers and Restraints: Impact Analysis

14. Competition Landscape

• 14.1. Competition Dashboard
• 14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
• 14.3. Global Players
  • 14.3.1. BodyCap-Medical
  • 14.3.2. Philips Respironics
  • 14.3.3. Given Imaging Ltd.
  • 14.3.4. Olympus Corporation
  • 14.3.5. Proteus Digital Health, Inc.
  • 14.3.6. CapsoVision, Inc.
  • 14.3.7. Chongqing Jinshan Science and Component (Group) Co., Ltd.
  • 14.3.8. Medimetrics
  • 14.3.9. IntroMedic Co., Ltd.
  • 14.3.10. Check-Cap Ltd.
• 14.4. Assumptions and Acronyms Used
• 14.5. Research Methodology

관련자료